NATIXIS ADVISORS, L.P. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$664
-33.1%
41,854
-20.4%
0.00%
-33.3%
Q2 2023$992
+268.8%
52,572
-2.9%
0.00%
+200.0%
Q4 2022$269
-99.9%
54,165
-0.8%
0.00%0.0%
Q3 2022$261,000
+12.5%
54,593
+5.8%
0.00%0.0%
Q2 2022$232,000
-6.5%
51,616
-1.1%
0.00%0.0%
Q1 2022$248,000
-40.4%
52,205
-6.9%
0.00%
-50.0%
Q4 2021$416,000
+90.8%
56,076
+46.2%
0.00%
+100.0%
Q3 2021$218,000
-16.8%
38,363
-3.3%
0.00%0.0%
Q2 2021$262,000
-20.8%
39,687
-3.1%
0.00%
-50.0%
Q1 2021$331,000
+6.8%
40,952
-14.8%
0.00%0.0%
Q4 2020$310,000
-63.7%
48,078
-79.7%
0.00%
-60.0%
Q3 2020$854,000
-23.3%
237,184
-2.1%
0.01%
-28.6%
Q2 2020$1,114,000
+19.3%
242,171
-11.6%
0.01%
-12.5%
Q1 2020$934,000
-33.2%
273,844
-0.1%
0.01%
-20.0%
Q4 2019$1,399,000
+101.3%
274,130
-4.5%
0.01%
+66.7%
Q3 2019$695,000
+41.5%
287,150
+26.8%
0.01%
+50.0%
Q2 2019$491,000
+58.9%
226,468
+98.4%
0.00%
+33.3%
Q1 2019$309,000
-71.7%
114,148
-49.8%
0.00%
-40.0%
Q4 2018$1,090,000
+5.8%
227,454
+109.0%
0.01%
-44.4%
Q3 2018$1,030,000
-60.6%
108,810
-59.5%
0.01%
-25.0%
Q2 2018$2,612,000
+4.7%
268,608
+13.3%
0.01%
-52.0%
Q1 2018$2,494,000
+38.6%
237,072
-15.6%
0.02%
+38.9%
Q4 2017$1,800,000
-17.6%
280,861
-1.7%
0.02%
-21.7%
Q3 2017$2,185,000
+4.8%
285,678
-2.6%
0.02%0.0%
Q2 2017$2,085,000
+79.3%
293,231
-2.5%
0.02%
+76.9%
Q1 2017$1,163,000
+99.5%
300,599
+5.1%
0.01%
+85.7%
Q4 2016$583,000
-7.0%
285,970
+22.3%
0.01%
-12.5%
Q3 2016$627,000
-30.8%
233,853
-20.5%
0.01%
-38.5%
Q2 2016$906,000
-43.5%
294,290
+56.4%
0.01%
-45.8%
Q1 2016$1,604,000
-23.7%
188,207
+21.6%
0.02%
-29.4%
Q4 2015$2,101,000
+47.1%
154,830
+4.1%
0.03%
+36.0%
Q3 2015$1,428,000
-35.3%
148,718
-3.1%
0.02%
-32.4%
Q2 2015$2,208,000
+71.2%
153,521
+6.6%
0.04%
+60.9%
Q1 2015$1,290,000
+129.5%
144,081
+56.3%
0.02%
+109.1%
Q4 2014$562,000
-38.9%
92,187
+6.1%
0.01%
-38.9%
Q3 2014$920,000
+8.5%
86,872
+21.4%
0.02%
+50.0%
Q2 2014$848,000
-12.8%
71,536
+9.9%
0.01%
-20.0%
Q1 2014$972,000
+16.4%
65,080
+14.3%
0.02%
+7.1%
Q4 2013$835,000
-3.6%
56,935
+12.0%
0.01%
-12.5%
Q3 2013$866,000
+0.3%
50,853
-2.2%
0.02%
-5.9%
Q2 2013$863,00052,0140.02%
Other shareholders
IMMUNOGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders